Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Relative Contribution of Brain Insulin Action for Postprandial Metabolism [NA]

View source ↗

Summary

This is an update on an active University of Ulm clinical trial evaluating the relative contribution of brain insulin action to postprandial glucose metabolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Ulm | Conditions: Glucose Metabolism Disorders | NA | Status: ACTIVE_NOT_RECRUITING